Delivery Order SPE2DB20D2104-SPE2DB23FU11Y
Award Date 6/23/23
Potential Completion Date 6/26/23
Potential Value $6.9K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,744.44 for the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999.00,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,168.33 for the supply of the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 27, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $28,577.16 delivery order contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of January 31, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $9,367.78 for the supply of XIFAXAN 550 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB20D3104|SPE2DB23FV4N1) valued at $2,666.97 for the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The award was made on January 4, 2023, with a completion date of January 5, 2023, and is a firm fixed-price contract. The contracting agency is the Defense Logistics Agency (DLA), a defense agency, and the contract is not designated with a set-aside. Amerisourcebergen Drug Corp...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $10,945.66 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the supply of XIFAXAN 550 MG TABLET 60S. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,762.05 firm-fixed-price delivery order is for the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The contract has an ultimate completion date of September 27, 2023. Amerisourcebergen Drug Corp holds two significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $38,010.99 Firm Fixed Price Delivery Order is for the pharmaceutical product XIFAXAN 550 MG TABLET 60S. This award is part of a larger Indefinite Delivery Contract (IDC) the DLA has with Cencora, Inc. valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $6,437.97 firm-fixed-price delivery order from the Defense Logistics Agency (DLA) for the supply of XIFAXAN 550 MG tablets. The contract has an ultimate completion date of January 30, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award to AmerisourceBergen Drug Corp., a subsidiary of Cencora, Inc., is a delivery order valued at $48,893.33 to provide the pharmaceutical product XIFAXAN 550 MG TABLET 60S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of May 7, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...